Safety of Tranexamic Acid Studied for Orthopedic Surgery in High-Risk Patients
Risk for complications not increased in patients with preexisting comorbidities undergoing hip or knee arthroplasty
Miscellaneous Musculoskeletal Disorders
MPR Weekly Dose Podcast 78
This week we have news of a COVID-19 vaccine authorization expansion for adolescents; A new postoperative pain treatment; There’s a new insulin smart pen devices; Insulin products are recalled; And the FDA grants fast track status to a potential treatment for the rare disease, FSHD.
Prescribing Up for Drugs Associated With Falls in Older Adults
Concurrent rise seen in fall-related mortality in older adults in the United States from 1999 to 2017
Do Successive Transfers of an Emergency Patient Amount to an EMTALA Violation?
This month we look at a case involving the Emergency Medical Treatment and Labor Act, commonly referred to as EMTALA. EMTALA was enacted by Congress in 1986 as part of the Consolidated Omnibus Budget Reconciliation Act (COBRA) of 1985. The act was designed to prevent hospitals from ‘patient dumping’; transferring uninsured or Medicaid patients to…
No Effect of Low-Dose Atorvastatin Found for Muscle Symptoms
For participants reporting muscle symptoms when taking statins, no overall effect seen for atorvastatin 20mg vs placebo
Digital Health App Tracks Pain Progress With Neurostimulation Therapy
Patients will be able to share information collected in the app with health care providers to provide a comprehensive assessment of the SCS or DRG therapy.
Most Users Report Cannabidiol Use for Treatment of Diagnosable Conditions
Psychiatric, orthopedic, and sleep issues most commonly cited in a Reddit forum
Investigational Gene Therapy Fast Tracked for Duchenne Muscular Dystrophy
PF-06939926 is a recombinant adeno-associated virus serotype 9 capsid carrying a shortened version of human dystrophin gene under the control of a human muscle-specific promoter.
Gabapentin Does Not Lower Pain Scores in Chronic Pelvic Pain
Treatment also linked to more serious adverse events.
MPR Weekly Dose Podcast Episode 50
We cover AstraZeneca’s decision to pause their COVID-19 vaccine trial; New studies indicate benefits for steroid therapy in COVID patients; Higher doses of diabetes treatment gain approval; The first non-hormonal contraceptive is launched; The FDA issues a letter regarding spinal cord stimulators; And we wrap up the latest news on drugs in the pipeline.
